Atropine Sulfate Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on Jan 1, 2012.

Shortage details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-631-25
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)
Initial Posting
Jan 1, 2012

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.